How to buy Oxford Immunotec Global stock - 07 March

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Oxford Immunotec Global stock

Own Oxford Immunotec Global stock in just a few minutes.

Fact checked

Oxford Immunotec Global PLC is a diagnostics & research business based in the US. Oxford Immunotec Global shares (OXFD) are listed on the NASDAQ and all prices are listed in US Dollars. Oxford Immunotec Global employs 273 staff and has a trailing 12-month revenue of around USD$57.3 million.

How to buy shares in Oxford Immunotec Global

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Oxford Immunotec Global. Find the stock by name or ticker symbol: OXFD. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Oxford Immunotec Global reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Oxford Immunotec Global, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Oxford Immunotec Global. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Oxford Immunotec Global share price

Use our graph to track the performance of OXFD stocks over time.

Oxford Immunotec Global shares at a glance

Information last updated 2021-03-03.
52-week rangeUSD$8.37 - USD$23.1081
50-day moving average USD$21.9318
200-day moving average USD$15.9926
Wall St. target priceUSD$22.5
PE ratio 11.746
Dividend yield N/A (0%)
Earnings per share (TTM) USD$5.18

Buy Oxford Immunotec Global shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get two free stock valued between $2.50 and $250
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
TradeStation
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Tastyworks
$0
Stocks, Options, Cryptocurrency
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
0%
Get 100 shares of stock (worth $1 to $6 a share)
Open and fund a new cash or margin account with $2,000+
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Interactive Brokers
$0
Stocks, Bonds, Options
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Oxford Immunotec Global stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Oxford Immunotec Global under- or over-valued?

Valuing Oxford Immunotec Global stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Oxford Immunotec Global's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Oxford Immunotec Global's P/E ratio

Oxford Immunotec Global's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 12x. In other words, Oxford Immunotec Global shares trade at around 12x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Oxford Immunotec Global financials

Revenue TTM USD$57.3 million
Gross profit TTM USD$54.4 million
Return on assets TTM -4.99%
Return on equity TTM -8.19%
Profit margin -30.51%
Book value $7.367
Market capitalisation USD$561.9 million

TTM: trailing 12 months

Shorting Oxford Immunotec Global shares

There are currently 136,459 Oxford Immunotec Global shares held short by investors – that's known as Oxford Immunotec Global's "short interest". This figure is 11.1% down from 153,441 last month.

There are a few different ways that this level of interest in shorting Oxford Immunotec Global shares can be evaluated.

Oxford Immunotec Global's "short interest ratio" (SIR)

Oxford Immunotec Global's "short interest ratio" (SIR) is the quantity of Oxford Immunotec Global shares currently shorted divided by the average quantity of Oxford Immunotec Global shares traded daily (recently around 974707.14285714). Oxford Immunotec Global's SIR currently stands at 0.14. In other words for every 100,000 Oxford Immunotec Global shares traded daily on the market, roughly 140 shares are currently held short.

However Oxford Immunotec Global's short interest can also be evaluated against the total number of Oxford Immunotec Global shares, or, against the total number of tradable Oxford Immunotec Global shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Oxford Immunotec Global's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Oxford Immunotec Global shares in existence, roughly 10 shares are currently held short) or 0.0077% of the tradable shares (for every 100,000 tradable Oxford Immunotec Global shares, roughly 8 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Oxford Immunotec Global.

Find out more about how you can short Oxford Immunotec Global stock.

Oxford Immunotec Global share dividends

We're not expecting Oxford Immunotec Global to pay a dividend over the next 12 months.

Oxford Immunotec Global share price volatility

Over the last 12 months, Oxford Immunotec Global's shares have ranged in value from as little as $8.37 up to $23.1081. A popular way to gauge a stock's volatility is its "beta".

OXFD.US volatility(beta: 1.38)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Oxford Immunotec Global's is 1.3831. This would suggest that Oxford Immunotec Global's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Oxford Immunotec Global overview

Oxford Immunotec Global PLC, a diagnostics company, focuses on developing and commercializing proprietary tests for immunology and infectious diseases in the United States, Europe, Asia, and internationally. The company develops its products using its T-SPOT technology platform that measures marker-specific cellular (T cells) responses at a single cell level and inform the diagnosis, prognosis, and monitoring of patients with immune-regulated conditions. It develops and markets T-SPOT.TB test used to test for tuberculosis; and reagents and methods to purify white blood cells for use in immunology assays. In addition, the company offers T-SPOT.CMV, an immune monitoring test for cytomegalovirus (CMV) for the quantification of effector T cells that respond to stimulation by antigens specific for CMV, as well as for the monitoring of CMV-seropositive responses in transplant recipients at various time-points post-transplantation applications. It serves independent laboratories, hospital systems, and public and private institutions. Oxford Immunotec Global PLC was founded in 2002 and is headquartered in Abingdon, the United Kingdom.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site